Crossmark

Diagnostic performance of pre-management computed tomography findings as a predictor of conservative treatment success in patients with emphysematous pyelonephritis

Crossref DOI link: https://doi.org/10.1186/s43055-022-00941-7

Published Online: 2022-12-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Badawy, Mohamed Ali

Abdelbaset, Mohamed

Zahran, Mohamed

Ghobrial, Fady Kamal

El-Ghar, Mohamed Abou

Elsorougy, Ali

Abdelhamid, Abdalla https://orcid.org/0000-0001-7882-7145
License Information

Text and Data Mining valid from 2022-12-12

Version of Record valid from 2022-12-12
More Information

Article History

Received: 14 September 2022

Accepted: 5 December 2022

First Online: 12 December 2022

Declarations

:

: This study was approved by the Research Ethics Committee of the Faculty of Medicine at Mansoura University in Egypt. After receiving approval from the institutional review board number R.21.06.1357.

: All patients included in this research gave written informed consent to publish the data contained within this study.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below